Trends in the incidence of visual impairment certification secondary to diabetic retinopathy in the Leeds metropolitan area, 2005-2010

Diabetic Medicine

Volumn 29, Issue 7, 2012, Pages

  Arora, S ^a   Kolb, S ^a   Goyder, E ^b   Mckibbin, M ^a  

^a ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^b UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

Diabetic retinopathy; Screening; Visual impairment

Indexed keywords

ADULT; ARTICLE; CERTIFICATION; CLINICAL ASSESSMENT; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC RETINOPATHY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE SEVERITY; GLAUCOMA; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; MEDICAL SERVICE; PREVALENCE; RETINA DEGENERATION; RETINA MACULA AGE RELATED DEGENERATION; RISK FACTOR; SCREENING TEST; TREND STUDY; VISUAL IMPAIRMENT;

ADULT; AGED; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; DISABILITY EVALUATION; ENGLAND; FEMALE; HUMANS; INCIDENCE; MALE; MASS SCREENING; MIDDLE AGED; RETROSPECTIVE STUDIES; VISION DISORDERS;

EID: 84862698496     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2012.03619.x     Document Type: Article

References (21)

1. Kohner E, Allwinkle J, Andrews J, Baker R, Brown F, Cheng H et al. Saint Vincent and improving diabetes care: Report of the Visual Handicap Group. Diabet Med 1996; 13(Suppl 4): s13-s26.
2. NHS Information Centre. Quality and Outcomes Framework. Available at Last accessed 1 July 2011.
3. Minassain D, Reidy A. An Epidemiological and Economic Model for Sight Loss in the Decade 2010-2020. Royal National Institute for the Blind, June 2009. Available at Last accessed 1 July 2011.
4. Hawthorne CL. An Analysis of the Costs of Visual Impairment and Blindness in the United Kingdom. A report prepared by Ethical Strategies Ltd for The Guide Dogs for the Blind Association July 2003. Available at Last accessed 1 July 2011.
5. Lafuma A, Brézin A, Lopatriello S, Hieke K, Hutchinson J, Mimaud V et al. Evaluation of non-medical costs associated with visual impairment in four European countries: France, Italy, Germany and the UK. Pharmacoeconomics. 2006; 24: 193-205.
6. Early Treatment Diabetic Retinopathy Study Group. Early photocoagulation for diabetic retinopathy. ETDRS report number 9. Ophthalmology 1991; 98(5 Suppl): 766-785.
7. Early Treatment Diabetic Retinopathy Study Research Group. Treatment techniques and clinical guidelines for photocoagulation of diabetic macular edema. ETDRS report Number 2. Ophthalmology 1987; 94: 761-774.
8. National Screening Programme for Diabetic Retinopathy. Available at Last accessed 1 July 2011.
9. Holman N, Forouhi NG, Goyder E, Wild SH. The APHO Diabetes Prevalence Model: estimates of total diabetes prevalence for England, 2010-2030. Diabet Med 2011; 28: 575-582.
10. UK National Statistics. Available at Last accessed 1 July 2011.
11. Hayat H, Nayak D, Ashiq A, Goyder E, Bodansky HJ, McKibbin M. Risk factors for visual impairment registration due to diabetic retinopathy in Leeds, 2002-2005. Pract Diabetes Int 2009; 26: 103-106.
12. Patel A, Oxley L, McKibbin M. Avoidable and unavoidable risk factors for visual impairment certification secondary to diabetic retinopathy. Poster presentation. Annual Congress of the Royal College of Ophthalmologists, May 2011.
13. Bunce C, Wormald R. Leading causes of certification for blindness and partial sight in England and Wales. BMC Public Health 2006; 6: 58.
14. Arun CS, Al-Bermani A, Stannard K, Taylor R. Long-term impact of retinal screening on significant diabetes-related visual impairment in the working age population. Diabet Med 2009; 26: 489-492.
15. Arun CS, Ngugi N, Lovelock L, Taylor R. Effectiveness of screening in preventing blindness due to diabetic retinopathy. Diabet Med 2003; 20: 186-190.
16. Vallance JH, Wilson PJ, Leese GP, McAlpine R, MacEwen CJ, Ellis JD. Diabetic retinopathy: more patients, less laser: a longitudinal population-based study in Tayside, Scotland. Diabetes Care 2008; 31: 1126-1131.
17. The Diabetes Control and Complications Trial Research Group. Progression of retinopathy with intensive versus conventional treatment in the diabetes control and complications trial. Ophthalmology 1995; 102: 647-661.
18. The United Kingdom Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type II diabetes. BMJ 1998; 317: 703-713.
19. Lewis K, Patel D, Yorston D, Charteris D. A qualitative study in the United Kingdom of factors influencing attendance by patients with diabetes at ophthalmic outpatient clinics. Ophthalmic Epidemiol 2007; 14: 375-80.
20. Cormack TG, Grant B, Macdonald MJ, Steel J, Campbell IW. Incidence of blindness due to diabetic eye disease in Fife 1990-9. Br J Ophthalmol 2001; 85: 354-356.
21. Bunce C, Xing W, Wormald R. Causes of blind and partial sight certifications in England and Wales: April 2007-March 2008. Eye (Lond) 2010; 24: 1692-1699.